drugset / Trial / NCT02339428

Diclophenac Versus Placebo for Pain Control in Diagnostic Colonoscopy

NCT02339428

Phase 3 Completed 90 enrolled University Hospital Rijeka
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Patients will be randomized to receive diclophenac sodium or placebo two hours before diagnostic colonoscopy. Intensity of pain as measured on a 10-point Likert scale will be the primary outcome. Patients will be followed until hospital discharge, an average of 10 days.

Timeline

Start
2015-01
Primary completion
2016-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 100 mg Oral

Indications